FINWIRES · TerminalLIVE
FINWIRES

Cintas Q4 Likely to Beat Estimates Amid Headwinds, RBC Says

By

Cintas (CTAS) is expected to beat fiscal Q4 estimates amid headwinds from higher energy costs, RBC Capital Markets said in a Thursday note.

The report said incremental margins in the low-to-mid 30% range can offset headwinds from energy costs and some 8% organic growth despite tougher year-over-year comparisons.

"Strong momentum should drive the upper end of FY27 guidance above our and consensus estimates," the note said.

On the UniFirst (UNF) acquisition, the note said deal closing is highly probable without requiring branch divestitures.

RBC has a sector perform rating and $206 price target on Cintas.

Price: $172.55, Change: $-0.52, Percent Change: -0.30%

Related Articles

Wire

Datadog 'Well Positioned' to Benefit From Rising Observability Spending, RBC Says

Datadog (DDOG) remains "well positioned" to benefit from rising "observability" spending driven by cloud migration, artificial intelligence adoption and continued product innovation, RBC Capital Markets said in a report emailed Friday.Following a meeting with the company's management, the firm said Datadog continues to gain market share as customers "consolidate" around its platform and invest in AI-driven modernization, with product innovation, expanding sales capacity and growing customer adoption supporting "durable" growth.AI-driven infrastructure modernization is Datadog's largest long-term opportunity, positioning the company as a preferred platform for managing production environments, the firm said.While emerging opportunities such as AI "training workloads," token cost management and "Bits AI SRE" could provide additional growth over time, the firm said the core investment thesis remains centered on Datadog's leadership in observability and "production environments."RBC maintained an outperform rating on Datadog and raised its price target to $250 from $219.Price: $239.67, Change: $+14.43, Percent Change: +6.40%

$DDOG
Wire

HealthEquity Posts Q1 Beat-and-Raise on Strong HSA Growth, AI-Driven Efficiency, RBC Says

HealthEquity (HQY) delivered a strong start to fiscal 2027 with a Q1 earnings beat and raise outlook, supported by above-market health savings account growth and meaningful operational leverage, RBC Capital said in a Friday note.The analysts noted that HSA accounts rose 8% year over year, outpacing broader market growth, with the company reporting its strongest enterprise sales pipeline in years and benefiting from expanded offerings and improved digital engagement.RBC highlighted meaningful operational leverage driven by AI deployment and service optimization, with service costs declining despite higher account volumes as automation reduced manual workloads and improved efficiency across servicing functions, according to the report.The investment firm also pointed to potential long-term regulatory tailwinds that could expand the HSA addressable market, though it cautioned that near-term labor market softness could moderate account growth and balance expansion in future periods.RBC raised its price target on the stock to $108 from $100 while maintaining its outperform rating.Shares of HealthEquity were down nearly 1% in Friday trading.Price: $89.72, Change: $-0.80, Percent Change: -0.88%

$HQY
Wire

HEICO's Fiscal Q2 Growth, Margin Performance Due to Market Share Gains, New Product Development, RBC Says

HEICO's (HEI) fiscal Q2 growth and margin performance was due to continued market share gains, new product development and pricing, RBC Capital Markets said in a Thursday research note.RBC said that the highlight of Q2 was the margins, with the company's Flight Support Group segment posting margins of over 26%, with the company calling out a 60 basis points of margin benefit from the accelerated shipment of some defense products.Meanwhile, the Electronic Technologies Group posted segment margins of 26.5%, well ahead of expectations after the sub-20% margins in Q1, the note said.RBC said that the company's strong balance sheet position provides significant mergers and acquisition capacity, and that it continues to view incremental M&A as positive for sentiment, with a larger transaction expected to a positive for the stock.RBC raised its price target on the company's stock to $390 from $375 and maintained its outperform rating.Price: $351.15, Change: $+6.08, Percent Change: +1.76%

$HEI$HEI.A